$REGN stock has now risen 2% today, according to our price data from Polygon. There has been approximately $237,772,558 of trading volume.
It has been the 477th most-searched ticker on Quiver Quantitative over the last day, out of 10,080 total tickers searched.
Here is what we see in our data on $REGN (you can track the company live on Quiver's $REGN stock page):
$REGN Insider Trading Activity
$REGN insiders have traded $REGN stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $REGN stock by insiders over the last 6 months:
- CHRISTINE A POON has made 0 purchases and 6 sales selling 6,500 shares for an estimated $4,252,745.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$REGN Hedge Fund Activity
We have seen 604 institutional investors add shares of $REGN stock to their portfolio, and 671 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 4,271,533 shares (-56.2%) from their portfolio in Q2 2025, for an estimated $2,242,554,825
- JPMORGAN CHASE & CO removed 1,718,579 shares (-30.4%) from their portfolio in Q2 2025, for an estimated $902,253,975
- DODGE & COX added 1,502,198 shares (+64.6%) to their portfolio in Q2 2025, for an estimated $788,653,950
- PRICE T ROWE ASSOCIATES INC /MD/ removed 1,408,582 shares (-64.8%) from their portfolio in Q2 2025, for an estimated $739,505,550
- CAPITAL INTERNATIONAL INVESTORS removed 823,869 shares (-20.7%) from their portfolio in Q2 2025, for an estimated $432,531,225
- AMUNDI removed 706,770 shares (-44.1%) from their portfolio in Q2 2025, for an estimated $371,054,250
- CITADEL ADVISORS LLC added 605,603 shares (+808.5%) to their portfolio in Q2 2025, for an estimated $317,941,575
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$REGN Congressional Stock Trading
Members of Congress have traded $REGN stock 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $REGN stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN purchased up to $15,000 on 05/15.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$REGN Analyst Ratings
Wall Street analysts have issued reports on $REGN in the last several months. We have seen 7 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Cantor Fitzgerald issued a "Overweight" rating on 10/29/2025
- Guggenheim issued a "Buy" rating on 10/29/2025
- Citigroup issued a "Buy" rating on 10/29/2025
- B of A Securities issued a "Underperform" rating on 10/29/2025
- Canaccord Genuity issued a "Buy" rating on 10/14/2025
- Morgan Stanley issued a "Overweight" rating on 10/10/2025
- BMO Capital issued a "Outperform" rating on 08/04/2025
To track analyst ratings and price targets for $REGN, check out Quiver Quantitative's $REGN forecast page.
$REGN Price Targets
Multiple analysts have issued price targets for $REGN recently. We have seen 14 analysts offer price targets for $REGN in the last 6 months, with a median target of $748.0.
Here are some recent targets:
- Tim Anderson from B of A Securities set a target price of $627.0 on 10/29/2025
- Geoff Meacham from Citigroup set a target price of $700.0 on 10/29/2025
- Carter Gould from Cantor Fitzgerald set a target price of $740.0 on 10/29/2025
- Mohit Bansal from Wells Fargo set a target price of $615.0 on 10/29/2025
- Brian Abrahams from RBC Capital set a target price of $708.0 on 10/29/2025
- Yatin Suneja from Guggenheim set a target price of $865.0 on 10/29/2025
- John Newman from Canaccord Genuity set a target price of $850.0 on 10/23/2025
You can track data on $REGN on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
